Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 24% ± 11% | |
lung | 13 studies | 30% ± 13% | |
intestine | 7 studies | 22% ± 6% | |
eye | 6 studies | 25% ± 9% | |
bone marrow | 6 studies | 27% ± 8% | |
brain | 6 studies | 31% ± 13% | |
placenta | 5 studies | 37% ± 16% | |
liver | 5 studies | 25% ± 15% | |
lymph node | 5 studies | 24% ± 10% | |
pancreas | 4 studies | 54% ± 15% | |
uterus | 4 studies | 34% ± 5% | |
breast | 4 studies | 21% ± 1% | |
kidney | 3 studies | 20% ± 1% | |
thymus | 3 studies | 63% ± 33% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2969.09 | 459 / 459 | 100% | 68.89 | 1117 / 1118 |
adrenal gland | 100% | 2977.72 | 258 / 258 | 100% | 52.47 | 229 / 230 |
thymus | 100% | 3454.87 | 653 / 653 | 100% | 35.91 | 602 / 605 |
pancreas | 100% | 7875.60 | 328 / 328 | 99% | 24.51 | 176 / 178 |
lung | 100% | 3403.93 | 576 / 578 | 99% | 26.47 | 1144 / 1155 |
prostate | 99% | 2667.56 | 243 / 245 | 99% | 56.11 | 499 / 502 |
brain | 99% | 1836.76 | 2621 / 2642 | 97% | 14.79 | 682 / 705 |
esophagus | 100% | 3642.80 | 1443 / 1445 | 96% | 17.44 | 175 / 183 |
uterus | 100% | 3166.63 | 170 / 170 | 95% | 26.21 | 434 / 459 |
kidney | 99% | 1711.31 | 88 / 89 | 95% | 23.66 | 860 / 901 |
stomach | 100% | 2502.13 | 359 / 359 | 91% | 15.77 | 259 / 286 |
ovary | 100% | 2913.71 | 180 / 180 | 90% | 15.97 | 389 / 430 |
intestine | 99% | 1905.36 | 957 / 966 | 87% | 15.86 | 459 / 527 |
liver | 92% | 2930.44 | 209 / 226 | 93% | 21.88 | 377 / 406 |
bladder | 100% | 2508.00 | 21 / 21 | 85% | 15.04 | 430 / 504 |
skin | 94% | 2051.54 | 1696 / 1809 | 80% | 19.78 | 379 / 472 |
spleen | 100% | 2185.11 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.51 | 45 / 45 |
blood vessel | 100% | 3262.32 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2437.38 | 1200 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 3264.22 | 833 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 11.01 | 25 / 29 |
muscle | 81% | 914.89 | 651 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 72% | 1194.27 | 666 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 43% | 5.01 | 34 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051238 | Biological process | sequestering of metal ion |
GO_0007264 | Biological process | small GTPase-mediated signal transduction |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0003677 | Molecular function | DNA binding |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0001965 | Molecular function | G-protein alpha-subunit binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NUCB2 |
Protein name | Nucleobindin 2 Nesfatin 1 Nucleobindin-2 (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1] |
Synonyms | NEFA |
Description | FUNCTION: Calcium-binding protein which may have a role in calcium homeostasis (By similarity). Acts as a non-receptor guanine nucleotide exchange factor which binds to and activates guanine nucleotide-binding protein (G-protein) alpha subunit GNAI3 (By similarity). .; FUNCTION: [Nesfatin-1]: Anorexigenic peptide, seems to play an important role in hypothalamic pathways regulating food intake and energy homeostasis, acting in a leptin-independent manner. May also exert hypertensive roles and modulate blood pressure through directly acting on peripheral arterial resistance. . |
Accessions | ENST00000533926.5 A0A2R8Y6G7 E9PLR5 ENST00000526120.5 ENST00000530527.5 E9PKG6 ENST00000527735.1 ENST00000528644.5 A7LNF5 ENST00000527580.5 H0YEG8 A7LNF3 A0A097EV82 ENST00000531172.5 E9PRQ3 ENST00000529010.6 [P80303-1] E9PM22 A7LNF4 A0A1B0GXJ7 ENST00000533773.5 ENST00000530964.5 P80303 E9PJP3 ENST00000533738.6 H0YD18 E9PLR0 ENST00000529313.5 ENST00000323688.10 [P80303-2] ENST00000646648.1 E9PLE9 |